Abstract
Meningiomas are extremely common intracranial tumours. When classified based on their histological appearance, the majority (approximately 80%) are World Health Organisation (WHO) Grade 1 benign tumours. A small percentage of meningiomas are atypical (WHO Grade 2) or anaplastic (WHO Grade 3), with higher-grade tumours demonstrating aggressive clinical and pathological characteristics. There is a well-recognised relationship between meningioma growth during periods of elevated circulating female sex hormones; this has been demonstrated in pregnancy or with the administration of exogenous synthetic hormones.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
